|
CDCA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.991000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.056600E-01 |
| Normal-vs-Stage2 |
1.224610E-01 |
| Normal-vs-Stage3 |
4.947200E-01 |
| Normal-vs-Stage4 |
6.931400E-01 |
| Stage1-vs-Stage2 |
8.038900E-03 |
| Stage1-vs-Stage3 |
6.103000E-01 |
| Stage1-vs-Stage4 |
8.546600E-01 |
| Stage2-vs-Stage3 |
5.315600E-02 |
| Stage2-vs-Stage4 |
3.538400E-02 |
| Stage3-vs-Stage4 |
5.863400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.804000E-01 |
| Normal-vs-AfricanAmerican |
2.839000E-01 |
| Normal-vs-Asian |
5.687400E-01 |
| Caucasian-vs-AfricanAmerican |
1.346210E-01 |
| Caucasian-vs-Asian |
6.621800E-01 |
| AfricanAmerican-vs-Asian |
3.612400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.966400E-01 |
| Normal-vs-Female |
5.054600E-01 |
| Male-vs-Female |
9.376400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.213800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.974570E-01 |
| Normal-vs-Age(61-80Yrs) |
5.404400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.048800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.976100E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.824400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.702580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.052000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.494220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.692400E-01 |
| Classical-VS-Follicular |
1.56460000000358E-06 |
| Classical-VS-Other |
2.600600E-01 |
| Classical-VS-Normal |
6.998000E-01 |
| Tall-VS-Follicular |
9.74689999999612E-05 |
| Tall-VS-Other |
9.071800E-02 |
| Tall-VS-Normal |
7.981600E-01 |
| Follicular-VS-Other |
8.049800E-01 |
| Follicular-VS-Normal |
6.069800E-02 |
| Other-VS-Normal |
1.536850E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.351400E-01 |
| Normal-vs-N1 |
3.054800E-01 |
| N0-vs-N1 |
4.967800E-01 |
|
|
